"In the face of the shortage and possible discontinuation of crystalline insulin vials, what is the most favorable alternative for preparing dextrose–insulin solutions for the management of hyperkalemic patients? In which regimen are they recommended?"
Abstract
According to the available scientific evidence, the best alternative to the use of crystalline insulin in the treatment of hypercalcemia is the ultra–short-acting insulin lispro; since it provides the greatest amount of information regarding its efficacy (which shows no significant differences compared to crystalline insulin), its safety profile has been studied, and it is considered safer for patients with renal impairment.
Fields of Study & Subjects
Potassium and Related Disorders
Hyperglycemia and glycemic control in critically ill and hospitalized patients
Parathyroid Disorders and Treatments
Publication details
- Journal / source
- Zenodo (CERN European Organization for Nuclear Research)
- Publication date
- 4 March 2026
- Language
- EN